Altimmune (ALT) vs Evolus (EOLS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Evolus (EOLS) has outperformed Altimmune (ALT) over the past year, gaining 23.6% versus a loss of 32.3%. Over five years, EOLS leads with a +0.9% price change compared with -77.9% for ALT. Altimmune is the larger company by market cap ($517.4 million vs $511.2 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ALT | EOLS |
|---|---|---|
| Share price | $2.66 | $7.74 |
| Market cap | $517.42M | $511.23M |
| 1-day change | -0.37% | +4.88% |
| YTD return | -26.32% | +16.39% |
| 1-year return | -32.32% | +23.64% |
| 5-year return | -77.85% | +0.91% |
| Forward P/E | — | 26.46 |
| EPS (TTM) | $-0.76 | $-0.53 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $6.44 | $9.31 |
| 52-week low | $2.56 | $3.86 |
| Distance from 52-week high | -58.70% | -16.86% |
| Average volume | 4.19M | 901.46K |
| Shares outstanding | 194.52M | 66.05M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EOLS has outperformed ALT by 56.0 percentage points over the past year.
ALT vs EOLS FAQ
Which is bigger, Altimmune or Evolus?
Altimmune (ALT) is larger, with a market capitalization of $517.42M compared with $511.23M for Evolus (EOLS).
Which stock has performed better over the past year, ALT or EOLS?
EOLS returned +23.64% over the past 12 months, compared with -32.32% for ALT (price return, excluding dividends). Past performance does not predict future results.
Are Altimmune and Evolus in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.